🩺

Gastroenterology

53 drugs in pipeline from 10 companies

Drugs in Pipeline

Companies

Upcoming Catalysts

Phase 3 Trials

Upcoming Catalysts

Tomorrow

AGIOEarnings$2.0B

AGIO Earnings Report

Jul 30Confirmed

Source

Aug '26

MRKPhase 3$281.2B

✓Positive

SC Tulisokibart Phase 3 Est. Readout

SC Tulisokibart• Ulcerative Colitis1,020

Aug 2026~Confirmed

CT.gov

days

MRKPhase 3$281.2B

✓Positive

IV Tulisokibart Phase 3 Results Expected

IV Tulisokibart• Crohn's Disease1,020

Aug 1Confirmed

CT.gov

View all catalysts

Pipeline by Phase

Phase 3

Active Companies

CELG-RI

BRISTOL MYERS SQUIBB CO

Novartis AG

TEVA PHARMACEUTICAL INDUSTRIES LTD

Amgen Inc.

Gilead Sciences, Inc.

PharmaMar, S.A.

ASTRAZENECA PLC

TAKEDA PHARMACEUTICAL CO LTD

1 drugs

LLY

Eli Lilly and Company

2 drugs

ABT

ABBOTT LABORATORIES

4 drugs

Related Conditions

gastrointestinalgiliverhepaticcirrhosiscrohnulcerative colitisibsgerdpancreatitisceliacconstipationdiarrhea